5621 — Human Technologies Income Statement
0.000.00%
- ¥15bn
- ¥11bn
- ¥5bn
- 80
- 35
- 75
- 72
Annual income statement for Human Technologies, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|
Period Length: | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | Yuho |
Standards: | JAS | JAS | JAS |
Status: | Final | Final | Final |
Revenue | |||
Total Revenue | 3,585 | 4,223 | 5,035 |
Cost of Revenue | |||
Gross Profit | 2,634 | 2,999 | 3,418 |
Selling / General / Administrative Expenses | |||
Unusual Expense / Income | |||
Other Operating Expenses | |||
Total Operating Expenses | 2,976 | 3,898 | 4,515 |
Operating Profit | 608 | 326 | 520 |
Total Net Non Operating Interest Income / Expense | |||
Other Net Non Operating Costs | |||
Net Income Before Taxes | 602 | 326 | 501 |
Provision for Income Taxes | |||
Net Income After Taxes | 439 | 238 | 335 |
Net Income Before Extraordinary Items | |||
Net Income | 439 | 238 | 335 |
Adjustments to Net Income | |||
Income Available to Common Shareholders Excluding Extraordinary Items | |||
Income Available to Common Shareholders Including Extraordinary Items | |||
Diluted Net Income | 439 | 238 | 335 |
Diluted Weighted Average Shares | |||
Basic EPS Including Extraordinary Items | |||
Diluted EPS Including Extraordinary Items | |||
Diluted EPS Excluding Extraordinary Items | |||
Normalised Income Before Taxes | |||
Normalised Income After Taxes | |||
Normalised Income Available to Common Shareholders | |||
Diluted Normalised EPS | 46.9 | 26.4 | 35 |
Dividends per Share |